Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. | Nat Commun | 2023 | 38114518 | PubTator, text mining | PubMed |
| Bispecific antibodies revolutionizing breast cancer treatment: a comprehensive overview. | Front Immunol | 2023 | 38111570 | PubTator, text mining | PubMed |
| Identifying CD1c as a potential biomarker by the comprehensive exploration of tumor mutational burden and immune infiltration in diffuse large B cell lymphoma. | PeerJ | 2023 | 38099311 | PubTator, text mining | PubMed |
| Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development. | Front Immunol | 2023 | 38098489 | PubTator, text mining | PubMed |
| Cuproptosis-related long noncoding RNAs predicts overall survival and reveal immune microenvironment of bladder cancer. | Heliyon | 2023 | 38094043 | PubTator, text mining | PubMed |
| Broadening the horizon: potential applications of CAR-T cells beyond current indications. | Front Immunol | 2023 | 38090582 | PubTator, text mining | PubMed |
| Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design. | Front Immunol | 2023 | 38090568 | PubTator, text mining | PubMed |
| Killer instincts: natural killer cells as multifactorial cancer immunotherapy. | Front Immunol | 2023 | 38090565 | PubTator, text mining | PubMed |
| Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response. | Ther Adv Neurol Disord | 2023 | 38084102 | PubTator, text mining | PubMed |
| Circular RNAs: emerging players in asthma and COPD. | Front Cell Dev Biol | 2023 | 38078005 | PubTator, text mining | PubMed |
| Case Report: HAVCR2 mutation-associated Hemophagocytic lymphohistiocytosis. | Front Immunol | 2023 | 38077348 | PubTator, text mining | PubMed |
| FANCI serve as a prognostic biomarker correlated with immune infiltrates in skin cutaneous melanoma. | Front Immunol | 2023 | 38077326 | PubTator, text mining | PubMed |
| Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. | Front Oncol | 2023 | 38074633 | PubTator, text mining | PubMed |
| Human Papillomavirus Infection in Penile Cancer: Multidimensional Mechanisms and Vaccine Strategies. | Int J Mol Sci | 2023 | 38069131 | PubTator, text mining | PubMed |
| Modulation of CD8+ T Cell Responses by Radiotherapy-Current Evidence and Rationale for Combination with Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | 38069014 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma. | Cancers (Basel) | 2023 | 38067356 | PubTator, text mining | PubMed |
| Epigenetic and Genetic Keys to Fight HPV-Related Cancers. | Cancers (Basel) | 2023 | 38067286 | PubTator, text mining | PubMed |
| Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance. | Cells | 2023 | 38067114 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade. | Cancer Cell Int | 2023 | 38066642 | PubTator, text mining | PubMed |
| The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment. | Exp Hematol Oncol | 2023 | 38066523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=20